MCI of different etiologies differ on the Cognitive Assessment Battery

Abstract

The results suggest that CAB can differentiate between MCI patients with and without vascular disease and that their cognitive profiles differ. Furthermore, CAB classified the patients as vascular and non-vascular MCI with good sensitivity and specificity.

Cognitive screening instruments to identify vascular cognitive impairment: A systematic review

“…All the studies were conducted in an outpatient setting, where subjects were recruited by convenience or consecutive sampling from those attending geriatric medicine or neurology‐based memory clinics and dedicated referral centres (eg, a National CADASIL clinic), with additional participants including controls obtained from general practice or other community settings such as volunteer groups. Most studies were conducted in Europe (seven studies), with five in Asia, two in North America, and one in South America …”

“…In all, eight different types of CSIs (batteries or individuals tests, excluding subtests or combinations), used alone or in combination and some multiple times (27 when all subtests, scoring versions, and variants were counted, see Appendix), were found. These included short batteries of cognitive tests such as the MMSE (n = 4 papers), the MoCA (n = 4) and its shortened version, the MoCA Short (n = 1), the BMET (n = 3) and the Executive functioning and Memory Ratio (EMR) derived from the BMET (n = 1), the ACE‐Revised (ACE‐R) (n = 1), and the Cognitive Assessment Battery (CAB) (n = 1), which includes the following subtests: Symbol Digit Modalities Test (SDMT), immediate and delayed recall, the Boston Naming Test, the Stroop Colour Word Test, and the Clock Drawing Executive Test (CLOX) combined with cube drawing; each subtest was examined separately . The most commonly studied single‐item instrument was the CDT ( n = 5) with six different scoring systems reported: the Rouleau, Cahn, Babins and the AD Cooperative Study scoring methods, and two versions of the CLOX, ie, CLOX1 (free drawing) and CLOX2 (copying); the CDT was also combined with the MMSE and the CLOX was combined with the Cube Copying Test .…”

“…These included short batteries of cognitive tests such as the MMSE (n = 4 papers), the MoCA (n = 4) and its shortened version, the MoCA Short (n = 1), the BMET (n = 3) and the Executive functioning and Memory Ratio (EMR) derived from the BMET (n = 1), the ACE‐Revised (ACE‐R) (n = 1), and the Cognitive Assessment Battery (CAB) (n = 1), which includes the following subtests: Symbol Digit Modalities Test (SDMT), immediate and delayed recall, the Boston Naming Test, the Stroop Colour Word Test, and the Clock Drawing Executive Test (CLOX) combined with cube drawing; each subtest was examined separately . The most commonly studied single‐item instrument was the CDT ( n = 5) with six different scoring systems reported: the Rouleau, Cahn, Babins and the AD Cooperative Study scoring methods, and two versions of the CLOX, ie, CLOX1 (free drawing) and CLOX2 (copying); the CDT was also combined with the MMSE and the CLOX was combined with the Cube Copying Test . Other individual instruments included the TMT (types A and B) (n = 1), tests of delayed recall (n = 3), including the Delayed Memory Index (DMI) subtest from the Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS), and four tests of verbal fluency: the F‐A‐S Phonemic (letter) Fluency (n = 1), Categorical Fluency (n = 1), the combination of the Controlled Oral Word Association Test (COWAT) and the Rey Auditory Verbal Learning Test (RAVLT) (n = 1), and the Orthographical fluency subtest from the Taiwanese version of the FAB (n = 1) .…”

Changes in cognitive function and brain glucose metabolism in elderly women with subjective memory impairment: a 24-month prospective pilot study

“…Thus, a detailed and comprehensive neuropsychological testing would be necessary in cognitive assessments of individuals with SMI. The usefulness of a neuropsychological test battery was demonstrated in patients with MCI of different etiologies .…”

The Gothenburg MCI study: Design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

“…56 Furthermore, CAB was recently found to differentiate between MCI with and without vascular disease, in terms of both overall performance and cognitive profile. 57 A questionnaire specifically developed to examine subjects with SCI, the Sahlgrenska Academy Selfreported Cognitive Impairment Questionnaire, was developed and found to discriminate between SCI patients and healthy controls. 58 In a recent reliability study of WMC estimation, a visual rating scale, a manual volumetric, and an automatic method were compared.…”